Skip to Content

NeuroBo Pharmaceuticals entered a licensing agreement with Dong-A ST Co., Ltd. and a strategic partnership with one of the largest pharmaceutical group of companies in South Korea; Dong-A Socio Group.

Dong-A Socio Group was founded in 1932 and is the leading Korean pharmaceutical and over-the-counter medicinal products group of companies with capabilities in all aspects of the pharmaceutical industry including drug research from discovery stage, global clinical development, manufacturing small molecules to oligonucleotides and mRNA, marketing and sales of pharmaceutical products and biosimilars, and global logistics. Dong-A ST and Dong-A Socio Group of companies have successfully developed and launched drugs globally and continue to develop clinical candidates.